5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Max Healthcare Institute Ltd.

•
maxhealthcare.inBSE: 543220NSE: MAXHEALTH
Market Cap₹ 1,01,127 Cr.
Current Price
High / Low₹ 1,222 / 903
Stock P/E69.4
Book Value₹ 112
Price to Book8.83
Dividend Yield0.19 %
ROCE15.0 %
ROE14.5 %
Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company has consistently been profitable over the last 5 years
  • Company has delivered good sales growth of 27.3% CAGR over last 5 years
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.17x)
  • Company comfortably covers its interest (8.1x coverage)
  • Company maintains a comfortable, low leverage position

CONS

  • Receivables are growing faster than sales - a possible quality concern
  • Free cash flow has been persistently negative
  • Stock is trading at 8.8x its book value
  • Recurring exceptional / one-off items are inflating headline profit
  • Operating margins have contracted to 26.8% from 30.2%

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcareHospital & Healthcare Services
Part ofNIFTY 50NIFTYLARGEMIDCAP250NIFTY CONSUMPTIONNIFTY100 EQL WGTNIFTY TOTAL MKT
S.No.Name
1.APOLLOHOSP8875.0061.07127608.880.23610.4038.417043.5020.5621.7315.70
2.MAXHEALTH1039.0069.41101126.940.19322.964.872366.1716.7014.9725.29
3.MANIPALHOS733.10108.0796430.300.002434.30—30906.30—13.9323.83
4.FORTIS901.8064.9768082.130.11272.802.262545.0317.4614.0721.28
5.ASTERDM766.70209.7166831.130.0029.28-68.701310.6821.6011.2619.53
6.MEDANTA1459.5570.5639243.180.03157.25-1.091304.0526.5019.3821.99
7.NH1909.1047.8039014.520.24207.275.372683.6378.0516.2017.43
8.KIMS772.75158.8632456.000.0037.40-56.001179.5035.3311.5119.03
9.LALPATHLAB1916.7059.3732171.581.071705.001172.397977.001090.9529.5631.03
10.AGARWALEYE505.05107.9216011.410.0055.0244.56614.0225.9716.1427.75
11.VIJAYA1498.5082.3215434.210.1353.1037.61230.9822.8330.2842.66
12.RAINBOW1460.7551.9914836.350.2462.5416.23469.9933.1728.2528.65
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
1,2851,3631,3351,4231,5431,7071,8681,9102,0282,1352,0682,1432,366
9489769491,0401,1561,2571,3691,3981,5051,5601,5291,5361,970
Operating Profit337387386383387451499512523575538606396
OPM %26.26%28.42%28.90%26.89%25.11%26.39%26.72%26.79%25.79%26.93%26.04%28.30%16.73%
414546443541-40473733-34841
Interest1991121243452555554606771
Depreciation56586170778498101104108111123132
Profit before Tax303366360336321374309402400446365465436
Tax %20.89%24.49%19.56%25.08%26.47%24.59%22.69%20.75%23.09%-10.15%17.45%26.34%25.98%
Net Profit0000236282239319308491301342323
2.472.852.982.592.432.902.463.283.175.053.103.523.32

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
1,6081,7291,6911,0592,5083,9374,5635,4067,0288,3738,712
1,4681,6161,5469702,1242,9983,3353,9255,1886,1336,596
Operating Profit140113146893849381,2271,4811,8402,2412,116
OPM %8.73%6.52%8.60%8.37%15.30%23.84%26.90%27.40%26.19%26.76%24.28%
42556753-9912215218990116118
Interest10099101831791018460165235251
Depreciation969410346174221232245359447474
Profit before Tax-12-26813-697391,0641,3651,4061,6761,711
Tax %88.79%-8.46%102.28%-1.02%-66.79%18.11%-3.74%22.54%23.50%13.92%14.84%
Net Profit-1-29-013-1146051,1041,0581,0761,4421,457
EPS0.29-0.39-0.061.01-1.596.2411.3610.8811.0714.82—
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%8.80%13.78%13.55%13.49%—

COMPOUNDED SALES GROWTH

10 Years:
19%
5 Years:
27%
3 Years:
22%

COMPOUNDED PROFIT GROWTH

10 Years:
—
5 Years:
—
3 Years:
9%

STOCK PRICE CAGR

10 Years:
—
5 Years:
22%
3 Years:
19%
1 Year:
-12%

RETURN ON EQUITY

10 Years:
6%
5 Years:
13%
3 Years:
13%
Last Year:
15%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2026

Jul 3

₹ 0.20

Rs.2.0000 per share(20%)Final Dividend

2025

Jul 4

₹ 0.15

Rs.1.5000 per share(15%)Final Dividend

2024

Aug 23

₹ 0.15

Rs.1.5000 per share(15%)Final Dividend

2023

Sep 8

₹ 0.10

Rs.1.0000 per share(10%)Final Dividend

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital537537537537966970971972972973
Minority Interest-73-13300000000
6556304262,0164,6465,2916,3977,3698,2899,627
1,3901,5521,0131,1191,5641,4831,1951,8143,3373,574
Trade Payables214267292180436444543633800859
4234521,0871229311,0029961,2121,7882,152
Total Liabilities3,1463,3043,3553,9748,5439,18910,10212,00015,18617,184
2,2442,2272,1928516,5367,0187,0398,72111,49712,986
Capital Work in Progress4535862827105207445900592
0012,182111235
2328262754617680106114
0000000463687970
Cash & Bank2390121206534991,4681,099682701
8119241,0387671,2731,5061,3121,1901,3111,816
Total Assets3,1463,3043,3553,9748,5439,18910,10212,00015,18617,184

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
19111011783608501,4451,1221,4381,633
Cash from Investing-104-100-17-2,641-73-764-102-1,285-1,611-1,689
Cash from Financing-4812-742,353191-294-289-264-16359
4-6-2-210236-317893-428-3364

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
23.7423.7423.7423.7423.7423.7423.7223.7123.71
56.9857.2956.9354.7454.7651.8050.5645.3941.78
15.3615.1415.5517.5917.4120.0321.2026.3229.95
Government0.000.000.000.000.000.000.000.000.00
3.913.833.773.944.084.434.524.574.56

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-11
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

2026-09-11 - Max Healthcare Institute Limited has informed the Exchange about disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

2026-09-07
Copy of Newspaper Publication

2026-09-07 - Max Healthcare Institute Limited has informed the Exchange about newspaper publication in Form INC-26 regarding shifting of Registered office

2026-09-07
General Updates

2026-09-07 - Max Healthcare Institute Limited has informed the Exchange about update on infusion of funds in Kalinga Hospital Ltd.

2026-09-04
ESOP/ESOS/ESPS

2026-09-04 - Max Healthcare Institute Limited has informed the Exchange regarding allotment of Equity Shares under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022.

2026-09-03
Acquisition

2026-09-03 - Max Healthcare Institute Limited has informed the Exchange about infusion of funds in Kalinga Hospital Ltd.

2026-09-03
Press Release

2026-09-03 - Max Healthcare Institute Limited has informed the Exchange regarding a press release dated September 03, 2026, titled "Hon ble Union Home Minister and Cooperation Minister Shri Amit Shah Inaugurates New 400 Beds Tower at Max Smart Super Speciality Hospital, Saket".

2026-08-26
General Updates

2026-08-26 - Max Healthcare Institute Limited has informed the Exchange about disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

2026-08-20
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-20 - Max Healthcare Institute Limited has informed the Exchange about transcript of Earnings Call held on August 14, 2026

2026-08-19
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

2026-08-19 - Max Healthcare Institute Limited has informed the Exchange about disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

News

Recent coverage and analyst commentary for MAXHEALTH

Loading news…

🤖

AI Stock Analyst

Max Healthcare Institute Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme


5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login